The George Institute For Global Health
- Address
- International Tower 3, Level 18 300 Barangaroo Avenue
Sponsor Overview
Specializations
Chronic Kidney Disease
Research activity is centred on chronic kidney disease, with a focus on slowing loss of kidney function and supporting care for people receiving standard treatment. The studies examine therapies aimed at reducing the decline in estimated glomerular filtration rate and addressing progression across advanced stages of kidney impairment.
- Slowing progression of CKD
- Preserving eGFR
- Standard-of-care kidney disease management
Active work spans multiple collaborating sites and includes ongoing recruitment across several countries, reflecting a strong interest in treatment options for kidney disease.
Cardiovascular Disease in Advanced Kidney Disease
The sponsor also investigates cardiovascular outcomes in people with advanced chronic kidney disease and dialysis-dependent kidney failure. This area includes prevention of major heart and blood vessel disease events in populations with elevated cardiovascular risk.
- Cardiovascular death prevention
- Myocardial infarction and stroke risk reduction
- Peripheral arterial disease outcomes
These studies link nephrology and cardiology, with particular attention to people whose kidney disease is complicated by high vascular risk.
Therapeutic Innovation in Kidney and Vascular Medicine
Clinical research includes evaluation of new treatment approaches and combinations intended to improve outcomes in kidney disease and related cardiovascular disease. The therapeutic landscape includes agents designed to modify disease progression and reduce major vascular events in patients with advanced renal impairment.
- Investigational kidney disease therapies
- Combination treatment strategies
- Antithrombotic approaches in high-risk patients
Research activity is distributed across a broad international network of sites, supporting work in both renal medicine and vascular protection.
Sponsored Trials
| Trial Name | Country | Status |
|---|---|---|
| Evaluation of Finerenone and Drug Combinations in Slowing eGFR Decline in Patients with Chronic Kidney Disease: A Randomized, Placebo-Controlled Trial |  Greece Spain | Recruiting |
| Evaluation of Finerenone in Slowing eGFR Decline in Patients with Chronic Kidney Disease: A Randomized, Placebo-Controlled, Adaptive Platform Trial |  Italy | Not Yet Recruiting |
| Evaluation of Low-Dose Rivaroxaban for Cardiovascular Event Reduction in Patients with Advanced Chronic Kidney Disease or Dialysis Dependency |  Belgium France Germany | Not Recruiting |
Data & Insights
This sponsor works with 2 molecules, of which 0 are not being studied by other sponsors.
This sponsor has worked with 45 sites across their trial portfolio.
Therapeutic Focus
- 1.Nutritional and Metabolic Diseases2 trials211 other sponsors
- 2.Cardiovascular Diseases1 trial359 other sponsors
Partnered Research Centres
45 centres- Address
- Via Consolare Valeria N 1, 98124 Messina
- Address
- Hopitaux De Brabois, Rue Du Morvan, 54500 Vandoeuvre Les Nancy
- Address
- 264 Rue Saint Pierre, 13005 Marseille
- Address
- 45 Rue Du Docteur Leon Mangeney, 68100 Mulhouse
- Address
- Via Sergio Pansini 5, 80131 Naples
- Address
- Piazza Luigi Miraglia 2, 80138 Naples
Want to get in touch with this sponsor?
Send a question and we'll pass it on to The George Institute For Global Health.
Need a custom report on this sponsor?
Competitive positioning, market entry, partnership opportunities — tell us the question.
Is something out of date?
Tell us what needs correcting and we'll update this profile.